Novel and potent MICA/B antibody is therapeutically effective in KRAS LKB1 mutant lung cancer models.
Kowash RR, Sabnani M, Gray LT, Deng Q, Saleh NUA, Girard L, Naito Y, Masahiro K, Minna JD, Gerber DE, Koyama S, Liu ZL, Baruah H, Akbay EA.
Kowash RR, et al. Among authors: gray lt.
J Immunother Cancer. 2025 Jan 6;13(1):e009867. doi: 10.1136/jitc-2024-009867.
J Immunother Cancer. 2025.
PMID: 39762078
Free article.